Clinical research logistics in ophthalmic trials are not just about moving equipment or scheduling visits. They directly affect endpoint quality. When intraocular pressure (IOP), best corrected...
Read More
Ocular endpoints can become a failure point in otherwise well-designed clinical trials. When IOP measurements vary across sites, OCT imaging is not captured consistently, or BCVA assessments are not...
Read More
Key Takeaways A failed OCT scan in retina clinical trials does not just cost a rescan. It costs a visit window, a deviation filing, and sometimes the patient. The invoice never shows full damage....
Read More
In ophthalmology trials, dropout is often treated like an unfortunate reality. In practice, it is usually more predictable than teams assume and more preventable than protocols reflect.
Read More
In clinical trials that deal with ocular hypertension, intraocular pressure (IOP) is not just a measurement. It is often the primary determinant of regulatory credibility and treatment response...
Read More
Selecting an ophthalmology CRO is fundamentally a risk decision. Sponsors and clinical operations leaders are not just choosing a vendor; they are choosing how ocular endpoints will be protected...
Read More
Ophthalmology Clinical Trials: Strategic Growth, Scientific Innovation, and Execution Risk for Sponsors Key Takeaways Aging populations and chronic disease growth are expanding the patient pool for...
Read More